Logo image of JMM

NUVEEN MULTI-MARKET INCOME (JMM) Stock Price, Quote, News and Overview

NYSE:JMM - New York Stock Exchange, Inc. - US67075J1079 - Currency: USD

6.1  +0.02 (+0.33%)

Fundamental Rating

1

Taking everything into account, JMM scores 1 out of 10 in our fundamental rating. JMM was compared to 0 industry peers in the Unkown industry. JMM may be in some trouble as it scores bad on both profitability and health. JMM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year JMM was profitable.
The reported net income has been mixed in the past 5 years: JMM reported negative net income in multiple years.
JMM had a positive operating cash flow in each of the past 5 years.
JMM Yearly Net Income VS EBIT VS OCF VS FCFJMM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

Industry RankSector Rank
ROA 5.14%
ROE 7.27%
ROIC 2%
ROA(3y)-0.51%
ROA(5y)0.06%
ROE(3y)-0.89%
ROE(5y)-0.02%
ROIC(3y)2.01%
ROIC(5y)2.17%
JMM Yearly ROA, ROE, ROICJMM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

In the last couple of years the Profit Margin of JMM has declined.
JMM's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of JMM has declined.
Industry RankSector Rank
OM 48.83%
PM (TTM) 99.52%
GM 67.86%
OM growth 3Y-7.7%
OM growth 5Y-6.39%
PM growth 3YN/A
PM growth 5Y-2.95%
GM growth 3Y-5.93%
GM growth 5Y-4.85%
JMM Yearly Profit, Operating, Gross MarginsJMM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for JMM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, JMM has less shares outstanding
Compared to 1 year ago, JMM has a worse debt to assets ratio.
JMM Yearly Shares OutstandingJMM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
JMM Yearly Total Debt VS Total AssetsJMM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

JMM has an Altman-Z score of 0.86. This is a bad value and indicates that JMM is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.41 indicates that JMM is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACCN/A
JMM Yearly LT Debt VS Equity VS FCFJMM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.05 indicates that JMM may have some problems paying its short term obligations.
JMM has a Quick Ratio of 0.05. This is a bad value and indicates that JMM is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
JMM Yearly Current Assets VS Current LiabilitesJMM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 148.64% over the past year.
JMM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.52% yearly.
JMM shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.27%.
Measured over the past years, JMM shows a decrease in Revenue. The Revenue has been decreasing by -2.26% on average per year.
EPS 1Y (TTM)148.64%
EPS 3YN/A
EPS 5Y-5.52%
EPS Q2Q%935.22%
Revenue 1Y (TTM)27.27%
Revenue growth 3Y-2.18%
Revenue growth 5Y-2.26%
Sales Q2Q%14.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JMM Yearly Revenue VS EstimatesJMM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
JMM Yearly EPS VS EstimatesJMM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.98, the valuation of JMM can be described as correct.
Compared to an average S&P500 Price/Earnings ratio of 30.42, JMM is valued rather cheaply.
Industry RankSector Rank
PE 12.98
Fwd PE N/A
JMM Price Earnings VS Forward Price EarningsJMM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JMM Per share dataJMM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.99%, JMM is a good candidate for dividend investing.
JMM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 4.99%

5.2 History

JMM has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
JMM Yearly Dividends per shareJMM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
JMM Yearly Income VS Free CF VS DividendJMM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

More info and screens

NUVEEN MULTI-MARKET INCOME

NYSE:JMM (2/20/2025, 3:04:39 PM)

6.1

+0.02 (+0.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners64.4%
Inst Owner Change4.02%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap57.71M
Analysts0
Price TargetN/A
Short Float %0.04%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield 4.99%
Yearly Dividend0.35
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date02-14 2025-02-14 (0.029)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.98
Fwd PE N/A
P/S 12.86
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)0.47
EY7.7%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.47
BVpS6.49
TBVpS6.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 7.27%
ROCE 3.52%
ROIC 2%
ROICexc 2%
ROICexgc 2.02%
OM 48.83%
PM (TTM) 99.52%
GM 67.86%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.06%
ROE(3y)-0.89%
ROE(5y)-0.02%
ROIC(3y)2.01%
ROIC(5y)2.17%
ROICexc(3y)2.01%
ROICexc(5y)2.17%
ROICexgc(3y)2.04%
ROICexgc(5y)2.19%
ROCE(3y)3.48%
ROCE(5y)3.67%
ROICexcg growth 3Y-6.61%
ROICexcg growth 5Y-6.47%
ROICexc growth 3Y-6.05%
ROICexc growth 5Y-6.61%
OM growth 3Y-7.7%
OM growth 5Y-6.39%
PM growth 3YN/A
PM growth 5Y-2.95%
GM growth 3Y-5.93%
GM growth 5Y-4.85%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 0.86
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)148.64%
EPS 3YN/A
EPS 5Y-5.52%
EPS Q2Q%935.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.27%
Revenue growth 3Y-2.18%
Revenue growth 5Y-2.26%
Sales Q2Q%14.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.36%
EBIT growth 3Y-9.72%
EBIT growth 5Y-8.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.73%
FCF growth 3Y-8.27%
FCF growth 5Y-18.29%
OCF growth 1Y36.73%
OCF growth 3Y-8.27%
OCF growth 5Y-18.29%